Brief: Amplia Therapeutics Announces CEO Resignation
Sept 12 (Reuters) - Amplia Therapeutics Ltd ATX.AX :
* CEO RESIGNATION
* CEO AND MANAGING DIRECTOR JOHN LAMBERT, HAS GIVEN NOTICE
OF HIS
RESIGNATION TO BOARD
Source text for Eikon: ID:nASX4j7w7w
Further company coverage: ATX.AX
Recent news on Amplia Therapeutics
See all newsBrief: Amplia Therapeutics Signs Collaboration And Supply Agreement With Lilly
Australia's Amplia rises to 4-month high on Eli Lilly cancer drug trial collaboration
Brief: Amplia Therapeutics Says Warwick Tong Will Retire As Board Chairman
Brief: Amplia Therapeutics Reports Four Additional Complete Responses And Improved Overall Survival Data In Accent Pancreatic Cancer Trial
Brief: Amplia Therapeutics Requests Trading Halt Pending Clinical Trial Results Announcement